182 related articles for article (PubMed ID: 25675148)
1. An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis.
Maishman T; Copson E; Stanton L; Gerty S; Dicks E; Durcan L; Wishart GC; Pharoah P; ; Eccles D
Br J Cancer; 2015 Mar; 112(6):983-91. PubMed ID: 25675148
[TBL] [Abstract][Full Text] [Related]
2. Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study.
Copson E; Eccles B; Maishman T; Gerty S; Stanton L; Cutress RI; Altman DG; Durcan L; Simmonds P; Lawrence G; Jones L; Bliss J; Eccles D;
J Natl Cancer Inst; 2013 Jul; 105(13):978-88. PubMed ID: 23723422
[TBL] [Abstract][Full Text] [Related]
3. A population-based validation of the prognostic model PREDICT for early breast cancer.
Wishart GC; Bajdik CD; Azzato EM; Dicks E; Greenberg DC; Rashbass J; Caldas C; Pharoah PD
Eur J Surg Oncol; 2011 May; 37(5):411-7. PubMed ID: 21371853
[TBL] [Abstract][Full Text] [Related]
4. Family history and outcome of young patients with breast cancer in the UK (POSH study).
Eccles BK; Copson ER; Cutress RI; Maishman T; Altman DG; Simmonds P; Gerty SM; Durcan L; Stanton L; Eccles DM;
Br J Surg; 2015 Jul; 102(8):924-35. PubMed ID: 25989914
[TBL] [Abstract][Full Text] [Related]
5. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer.
Wishart GC; Azzato EM; Greenberg DC; Rashbass J; Kearins O; Lawrence G; Caldas C; Pharoah PD
Breast Cancer Res; 2010; 12(1):R1. PubMed ID: 20053270
[TBL] [Abstract][Full Text] [Related]
6. Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.
Copson ER; Maishman TC; Tapper WJ; Cutress RI; Greville-Heygate S; Altman DG; Eccles B; Gerty S; Durcan LT; Jones L; Evans DG; Thompson AM; Pharoah P; Easton DF; Dunning AM; Hanby A; Lakhani S; Eeles R; Gilbert FJ; Hamed H; Hodgson S; Simmonds P; Stanton L; Eccles DM
Lancet Oncol; 2018 Feb; 19(2):169-180. PubMed ID: 29337092
[TBL] [Abstract][Full Text] [Related]
7. Bridging the Age Gap: a prognostic model that predicts survival and aids in primary treatment decisions for older women with oestrogen receptor-positive early breast cancer.
Ward SE; Holmes GR; Morgan JL; Broggio JW; Collins K; Richards PD; Reed MWR; Wyld L
Br J Surg; 2020 Nov; 107(12):1625-1632. PubMed ID: 32602959
[TBL] [Abstract][Full Text] [Related]
8. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2017 Sep; 165(2):391-402. PubMed ID: 28601929
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
10. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Predict, a prognostic risk tool, after diagnosis of a second breast cancer.
Deng Z; Jones MR; Wolff AC; Visvanathan K
JNCI Cancer Spectr; 2023 Oct; 7(6):. PubMed ID: 37773987
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years.
Engelhardt EG; van den Broek AJ; Linn SC; Wishart GC; Rutgers EJT; van de Velde AO; Smit VTHBM; Voogd AC; Siesling S; Brinkhuis M; Seynaeve C; Westenend PJ; Stiggelbout AM; Tollenaar RAEM; van Leeuwen FE; van 't Veer LJ; Ravdin PM; Pharaoh PDP; Schmidt MK
Eur J Cancer; 2017 Jun; 78():37-44. PubMed ID: 28412587
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen receptors revisited: long-term follow up of over five thousand breast cancer patients.
Hähnel R; Spilsbury K
ANZ J Surg; 2004 Nov; 74(11):957-60. PubMed ID: 15550082
[TBL] [Abstract][Full Text] [Related]
14. Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer: The POSH Observational Cohort Study.
Maishman T; Cutress RI; Hernandez A; Gerty S; Copson ER; Durcan L; Eccles DM
Ann Surg; 2017 Jul; 266(1):165-172. PubMed ID: 27455160
[TBL] [Abstract][Full Text] [Related]
15. Incorporating progesterone receptor expression into the PREDICT breast prognostic model.
Grootes I; Keeman R; Blows FM; Milne RL; Giles GG; Swerdlow AJ; Fasching PA; Abubakar M; Andrulis IL; Anton-Culver H; Beckmann MW; Blomqvist C; Bojesen SE; Bolla MK; Bonanni B; Briceno I; Burwinkel B; Camp NJ; Castelao JE; Choi JY; Clarke CL; Couch FJ; Cox A; Cross SS; Czene K; Devilee P; Dörk T; Dunning AM; Dwek M; Easton DF; Eccles DM; Eriksson M; Ernst K; Evans DG; Figueroa JD; Fink V; Floris G; Fox S; Gabrielson M; Gago-Dominguez M; García-Sáenz JA; González-Neira A; Haeberle L; Haiman CA; Hall P; Hamann U; Harkness EF; Hartman M; Hein A; Hooning MJ; Hou MF; Howell SJ; ; ; Ito H; Jakubowska A; Janni W; John EM; Jung A; Kang D; Kristensen VN; Kwong A; Lambrechts D; Li J; Lubiński J; Manoochehri M; Margolin S; Matsuo K; Taib NAM; Mulligan AM; Nevanlinna H; Newman WG; Offit K; Osorio A; Park SK; Park-Simon TW; Patel AV; Presneau N; Pylkäs K; Rack B; Radice P; Rennert G; Romero A; Saloustros E; Sawyer EJ; Schneeweiss A; Schochter F; Schoemaker MJ; Shen CY; Shibli R; Sinn P; Tapper WJ; Tawfiq E; Teo SH; Teras LR; Torres D; Vachon CM; van Deurzen CHM; Wendt C; Williams JA; Winqvist R; Elwood M; Schmidt MK; García-Closas M; Pharoah PDP
Eur J Cancer; 2022 Sep; 173():178-193. PubMed ID: 35933885
[TBL] [Abstract][Full Text] [Related]
16. Predictors of time to death after distant recurrence in breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma.
Wijesinghe HD; Wijesinghe GK; Mansoor Z; Vigneshwara S; Fernando J; Gunasekera D; Lokuhetty MDS
BMC Womens Health; 2020 Sep; 20(1):206. PubMed ID: 32928183
[TBL] [Abstract][Full Text] [Related]
18. Individualized Prediction of Survival Benefit from Postmastectomy Radiotherapy for Patients with Breast Cancer with One to Three Positive Axillary Lymph Nodes.
Zhang N; Zhang J; Zhang H; Liu Y; Zhao W; Wang L; Chen B; Moran MS; Haffty BG; Yang Q
Oncologist; 2019 Dec; 24(12):e1286-e1293. PubMed ID: 31315963
[TBL] [Abstract][Full Text] [Related]
19. An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation.
Candido Dos Reis FJ; Wishart GC; Dicks EM; Greenberg D; Rashbass J; Schmidt MK; van den Broek AJ; Ellis IO; Green A; Rakha E; Maishman T; Eccles DM; Pharoah PDP
Breast Cancer Res; 2017 May; 19(1):58. PubMed ID: 28532503
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
